{"filing":{"accession":"0001106578-26-000126","url":"/filing/0001106578-26-000126","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-21","filed_date":"2026-08-24","acceptance_dt":"2026-08-24T16:30:23+00:00","acceptance_label":"2026-08-24 16:30 UTC","ingested_at":"2026-08-25T05:24:19.374141+00:00","ingested_label":"2026-08-25 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000126-index.htm","day_url":"/filings/2026-08-24"},"owners":[{"owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","url":"/insider/0001106578","anchor":"owner-0001106578","role":"Director, Officer (Chairperson & CEO)","officer_title":"Chairperson & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001106578-26-000126#owner-0001106578"}],"line_owners":[{"owner_name":"ROTHBLATT MARTINE A","role":"Director, Officer (Chairperson & CEO)"}],"transactions":[{"id":9300363,"accession":"0001106578-26-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1189.0,"shares_display":"1,189","price_per_share":512.7137,"price_display":"512.71","price_state":"stated","total_value":609616.5893,"total_display":"609,616.59","total_whole":"609,617","shares_owned_after":332754.0,"shares_owned_after_display":"332,754","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300364,"accession":"0001106578-26-000126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":271.0,"shares_display":"271","price_per_share":513.8536,"price_display":"513.85","price_state":"stated","total_value":139254.3256,"total_display":"139,254.33","total_whole":"139,254","shares_owned_after":332483.0,"shares_owned_after_display":"332,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300365,"accession":"0001106578-26-000126","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":515.2623,"price_display":"515.26","price_state":"stated","total_value":321523.6752,"total_display":"321,523.68","total_whole":"321,524","shares_owned_after":331859.0,"shares_owned_after_display":"331,859","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300366,"accession":"0001106578-26-000126","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1689.0,"shares_display":"1,689","price_per_share":516.1496,"price_display":"516.15","price_state":"stated","total_value":871776.6744,"total_display":"871,776.67","total_whole":"871,777","shares_owned_after":330170.0,"shares_owned_after_display":"330,170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300367,"accession":"0001106578-26-000126","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773.0,"shares_display":"773","price_per_share":517.0696,"price_display":"517.07","price_state":"stated","total_value":399694.8008,"total_display":"399,694.80","total_whole":"399,695","shares_owned_after":329397.0,"shares_owned_after_display":"329,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300368,"accession":"0001106578-26-000126","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1077.0,"shares_display":"1,077","price_per_share":518.1351,"price_display":"518.14","price_state":"stated","total_value":558031.5027,"total_display":"558,031.50","total_whole":"558,032","shares_owned_after":328320.0,"shares_owned_after_display":"328,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300369,"accession":"0001106578-26-000126","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":837.0,"shares_display":"837","price_per_share":519.0852,"price_display":"519.09","price_state":"stated","total_value":434474.3124,"total_display":"434,474.31","total_whole":"434,474","shares_owned_after":327483.0,"shares_owned_after_display":"327,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300370,"accession":"0001106578-26-000126","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":440.0,"shares_display":"440","price_per_share":520.0317,"price_display":"520.03","price_state":"stated","total_value":228813.948,"total_display":"228,813.95","total_whole":"228,814","shares_owned_after":327043.0,"shares_owned_after_display":"327,043","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300371,"accession":"0001106578-26-000126","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-9","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":371.0,"shares_display":"371","price_per_share":521.2808,"price_display":"521.28","price_state":"stated","total_value":193395.1768,"total_display":"193,395.18","total_whole":"193,395","shares_owned_after":326672.0,"shares_owned_after_display":"326,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300372,"accession":"0001106578-26-000126","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-10","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":669.0,"shares_display":"669","price_per_share":522.289,"price_display":"522.29","price_state":"stated","total_value":349411.341,"total_display":"349,411.34","total_whole":"349,411","shares_owned_after":326003.0,"shares_owned_after_display":"326,003","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300373,"accession":"0001106578-26-000126","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-11","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":455.0,"shares_display":"455","price_per_share":523.6208,"price_display":"523.62","price_state":"stated","total_value":238247.464,"total_display":"238,247.46","total_whole":"238,247","shares_owned_after":325548.0,"shares_owned_after_display":"325,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300374,"accession":"0001106578-26-000126","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-12","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":524.3515,"price_display":"524.35","price_state":"stated","total_value":327719.6875,"total_display":"327,719.69","total_whole":"327,720","shares_owned_after":324923.0,"shares_owned_after_display":"324,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300375,"accession":"0001106578-26-000126","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-13","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235.0,"shares_display":"235","price_per_share":525.4202,"price_display":"525.42","price_state":"stated","total_value":123473.747,"total_display":"123,473.75","total_whole":"123,474","shares_owned_after":324688.0,"shares_owned_after_display":"324,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300376,"accession":"0001106578-26-000126","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-14","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45.0,"shares_display":"45","price_per_share":526.4667,"price_display":"526.47","price_state":"stated","total_value":23691.0015,"total_display":"23,691.00","total_whole":"23,691","shares_owned_after":324643.0,"shares_owned_after_display":"324,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300377,"accession":"0001106578-26-000126","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001106578-26-000126","line_url":"/filing/0001106578-26-000126#line-15","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":527.708,"price_display":"527.71","price_state":"stated","total_value":105541.6,"total_display":"105,541.60","total_whole":"105,542","shares_owned_after":324443.0,"shares_owned_after_display":"324,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-24","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":15,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-25T05:24:19.374141+00:00","retrieved_label":"2026-08-25 05:24 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000126-index.htm","accepted_at":"2026-08-24T16:30:23+00:00","accepted_label":"2026-08-24 16:30 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001106578-26-000126","retrieved_at":"2026-08-27T07:50:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}